The Goldman Sachs Group, Inc. : One could take advantage of the euphoria
Entry price | Target | Stop-loss | Potential |
---|
$213.12 |
$200.7 |
$217.1 |
+5.83% |
---|
Pursuant to the strong advance that shares in Goldman Sachs Group Inc have seen recently, profit-taking could prompt a correction move.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● The group usually releases upbeat results with huge surprise rates.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
Weaknesses● Technically, the stock approaches a strong medium-term resistance at USD 215.52.
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.